The TGA has backed the European Medicines Agency in saying that vaccination with the AstraZeneca COVID-19 vaccine should not be deterred by reports of extremely rare cases of cerebral venous sinus thrombosis (CVST). Based on vaccine safety surveillance reports from countries such as Germany, the EMA statement said cases of thrombosis and thrombocytopenia, some presenting ...
Rare cases of cerebral thrombosis should not deter use of AstraZeneca vaccine: regulators
By Michael Woodhead
23 Mar 2021